All data are based on the daily closing price as of November 22, 2024
g
Grape King Bio
1707.TW
4.75 USD
0.01
+0.21%
Overview
Last close
4.75 usd
Market cap
704.31M usd
52 week high
5.93 usd
52 week low
4.09 usd
Target price
5.39 usd
Valuation
P/E
15.752
Forward P/E
17.3611
Price/Sales
2.1149
Price/Book Value
2.2914
Enterprise Value
606.63M usd
EV/Revenue
1.7627
EV/EBITDA
6.145
Key financials
Revenue TTM
333.44M usd
Gross Profit TTM
260.51M usd
EBITDA TTM
87.44M usd
Earnings per Share
0.3 usd
Dividend
N/A usd
Total assets
15.05B usd
Net debt
N/A usd
About
Grape King Bio Ltd, together with its subsidiaries, produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food in Taiwan, China, and internationally. It operates through Multi-Level Marketing; Distribution; and Original Design Manufacturer/Original Equipment Manufacturer segments. The company offers Chinese herbal, probiotics, energy drinks, and health food supplements for gastrointestinal health, immunity regulation, weight control, liver care, brain health, eye care, feminine health, and sensual health care. It also provides functional ingredients, microbial fermentation, and food inspection services. Grape King Bio Ltd was founded in 1969 and is headquartered in Taoyuan City, Taiwan.